Cancer Drug Parity Act of 2026
A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.
This bill aims to change the Employee Retirement Income Security Act of 1974 by requiring group health plans to offer the same cost-sharing for oral anticancer drugs as they do for anticancer medications given by a healthcare provider. This means that if you pay a certain amount for cancer medication given in a clinic, you should pay the same amount for similar cancer medication you take at home.
This bill will affect people with group health plans, especially those who are undergoing cancer treatment. If passed, it will help reduce the financial burden on patients by ensuring they don't pay more out-of-pocket for oral cancer drugs than for injectable ones.
The bill was introduced on July 15, 2026, and has been referred to the Committee on Health, Education, Labor, and Pensions. There are no further actions or history updates at this time.
